Adaptimmune Therapeutics Statistics

Total Valuation

ADAP has a market cap or net worth of $246.73 million. The enterprise value is $123.92 million.

Market Cap	246.73M
Enterprise Value	123.92M

Important Dates

The next estimated earnings date is Wednesday, August 7, 2024, before market open.

Earnings Date	Aug 7, 2024
Ex-Dividend Date	n/a

Share Statistics

ADAP has 234.98 million shares outstanding.

Shares Outstanding	234.98M
Owned by Insiders (%)	0.39%
Owned by Institutions (%)	64.17%
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	13.44
Forward PS	3.31
PB Ratio	10.12
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	6.75
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.81, with a Debt / Equity ratio of 0.97.

Current Ratio	2.81
Quick Ratio	2.33
Debt / Equity	0.97
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -234.60% and return on invested capital (ROIC) is -396.65%.

Return on Equity (ROE)	-234.60%
Return on Assets (ROA)	-55.40%
Return on Capital (ROIC)	-396.65%
Revenue Per Employee	$40,886
Profits Per Employee	-$363,942
Employee Count	449
Asset Turnover	0.06
Inventory Turnover	n/a

Taxes

In the past 12 months, ADAP has paid $1.24 million in taxes.

Income Tax	1.24M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +12.59% in the last 52 weeks. The beta is 2.33, so ADAP's price volatility has been higher than the market average.

Beta (5Y)	2.33
52-Week Price Change	+12.59%
50-Day Moving Average	1.06
200-Day Moving Average	0.94
Relative Strength Index (RSI)	55.32
Average Volume (20 Days)	1,610,583

Short Selling Information

Short Interest	4.90M
Short Previous Month	4.62M
Short % of Shares Out	2.88%
Short % of Float	n/a
Short Ratio (days to cover)	2.46

Income Statement

In the last 12 months, ADAP had revenue of $18.36 million and -$163.41 million in losses. Loss per share was -$0.66.

Revenue	18.36M
Gross Profit	18.36M
Operating Income	-190.66M
Pretax Income	-162.17M
Net Income	-163.41M
EBITDA	-151.35M
EBIT	-162.17M
Loss Per Share	-$0.66

Full Income Statement

Balance Sheet

The company has $146.51 million in cash and $23.69 million in debt, giving a net cash position of $122.82 million or $0.52 per share.

Cash & Cash Equivalents	146.51M
Total Debt	23.69M
Net Cash	122.82M
Net Cash Per Share	$0.52
Equity (Book Value)	24.38M
Book Value Per Share	0.10
Working Capital	120.49M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$135.55 million and capital expenditures -$2.43 million, giving a free cash flow of -$137.98 million.

Operating Cash Flow	-135.55M
Capital Expenditures	-2.43M
Free Cash Flow	-137.98M
FCF Per Share	-$0.57

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -1,038.56% and -890.13%.

Gross Margin	100.00%
Operating Margin	-1,038.56%
Pretax Margin	-883.39%
Profit Margin	-890.13%
EBITDA Margin	-824.43%
EBIT Margin	-883.39%
FCF Margin	-751.61%

Dividends & Yields

ADAP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-45.08%
Shareholder Yield	-45.08%
Earnings Yield	-66.23%
FCF Yield	-55.92%

Analyst Forecast

The average price target for ADAP is $4.29, which is 308.57% higher than the current price. The consensus rating is "Buy".

Price Target	$4.29
Price Target Difference	308.57%
Analyst Consensus	Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	26.40%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ADAP has an Altman Z-Score of -6.62 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.62
Piotroski F-Score	2